Docetaxel in Non-Small Cell Lung CancerImpact on Quality of Life and Pharmacoeconomics

被引:0
作者
Leora Horn
Antonio Visbal
Natasha B. Leighl
机构
[1] University of Toronto,Department of Medical Oncology, Princess Margaret Hospital/University Health Network
[2] University of Toronto,Department of Medical Oncology, Princess Margaret Hospital
来源
Drugs & Aging | 2007年 / 24卷
关键词
Paclitaxel; Docetaxel; Gemcitabine; Febrile Neutropenia; Vinorelbine;
D O I
暂无
中图分类号
学科分类号
摘要
Lung cancer is one of the leading causes of cancer-related deaths in industrialised countries, with non-small cell lung cancer (NSCLC) accounting for the majority of cases. A large proportion of patients present with advanced disease and are >65 years of age at the time of diagnosis.
引用
收藏
页码:411 / 428
页数:17
相关论文
共 155 条
  • [1] Parkin DM(2005)Global cancer statistics, 2002 CA Cancer J Clin 55 74-108
  • [2] Bray F(2003)Chemotherapy for elderly patients with advanced non-small-cell lung cancer J Natl Cancer Inst 95 341-3
  • [3] Ferlay J(1988)Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer: report of a Canadian multicenter randomized trial J Clin Oncol 6 633-41
  • [4] Bunn PA(2000)A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC) Lung Cancer 27 145-57
  • [5] Lilenbaum R(1988)Combination chemotherapy confers modest survival advantage in patients with advanced non-small cell lung cancer: report of a Canadian multicenter randomized trial Semin Oncol 15 42-5
  • [6] Rapp E(2005)Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature J Clin Oncol 23 2926-36
  • [7] Pater JL(1999)Underrepresentation of patients 65 years of age or older in cancer-treatment trials N Engl J Med 341 2061-7
  • [8] Willan A(2005)Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel J Clin Oncol 23 3125-37
  • [9] Roszkowski K(2003)Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial J Natl Cancer Inst 95 362-72
  • [10] Pluzanska A(2005)Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the Cancer and Leukemia Group B (study 9730) J Clin Oncol 23 190-6